Impact of Pharmacotherapy on Quality of Life in Patients with Parkinson's Disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2015 AND VI 29 AND IP 5
Results: 8
1
2
Topiramate in Alcohol Use Disorders: Review and Update.
- Published in:
- CNS Drugs, 2015, v. 29, n. 5, p. 383, doi. 10.1007/s40263-015-0244-0
- By:
- Publication type:
- Article
3
Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review.
- Published in:
- CNS Drugs, 2015, v. 29, n. 5, p. 425, doi. 10.1007/s40263-015-0245-z
- By:
- Publication type:
- Article
4
Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.
- Published in:
- CNS Drugs, 2015, v. 29, n. 5, p. 415, doi. 10.1007/s40263-015-0246-y
- By:
- Publication type:
- Article
5
Impact of Pharmacotherapy on Quality of Life in Patients with Parkinson 's Disease.
- Published in:
- CNS Drugs, 2015, v. 29, n. 5, p. 397, doi. 10.1007/s40263-015-0247-x
- By:
- Publication type:
- Article
6
Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review.
- Published in:
- CNS Drugs, 2015, v. 29, n. 5, p. 371, doi. 10.1007/s40263-015-0248-9
- By:
- Publication type:
- Article
7
Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation.
- Published in:
- CNS Drugs, 2015, v. 29, n. 5, p. 351, doi. 10.1007/s40263-015-0250-2
- By:
- Publication type:
- Article
8
Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date.
- Published in:
- CNS Drugs, 2015, v. 29, n. 5, p. 359, doi. 10.1007/s40263-015-0243-1
- By:
- Publication type:
- Article